2022 Annual Meeting | C135 - Autoimmune Neurology: Peripheral Nervous System

Date Wednesday 04/06/22

Time 01:00 PM - 03:00 PM PDT Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program will be available in the meeting's On Demand product.

Event Type Seminar

Director(s) Divyanshu Dubey, MD, FAAN

Topic(s) Autoimmune Neurology

Learning Objectives Participants should be able identify clinical phenotypes, electrodiagnostic, and histopathological features suggestive of serologically defined autoimmune or paraneoplastic neuromuscular presentations; and be familiar with the current diagnosis and management of neuromuscular immune-related adverse events from immune checkpoint inhibitor therapies. Advances in translational research to further characterize immune related adverse events will also be discussed. Participants should be familiar with current literature regarding parainfectious autoimmune or auto-inflammatory neuromuscular complications of COVID-19.

CME Available 2.00 CME credits

Core Competencies Patient Care & Procedural Skills, Medical Knowledge

Program Level Intermediate

Recommended Audience Fellow, Resident, General Neurologist, Specialist Neurologist, Advanced Practice Provider, Neurohospitalist, Medical Student

Teaching Styles Case-based

Program Materials Program Evaluations

Event Timeline
01:00 PM - 01:05 PM PDT	Introduction	Spectrum of Peripheral Nervous System Autoimmunity in the Era of Neural Specific Autoantibodies, Immune Checkpoint Inhibitors, and COVID19 Divyanshu Dubey, MD, FAAN
01:00 PM - 01:00 PM PDT	Speaker	Walk-in Slides Divyanshu Dubey, MD, FAAN
01:05 PM - 01:40 PM PDT	Speaker	Autoimmune Neuropathies Divyanshu Dubey, MD, FAAN
01:40 PM - 02:15 PM PDT	Speaker	Autoimmune Myopathies Anthony A. Amato, MD, FAAN
02:15 PM - 02:50 PM PDT	Speaker	Autoimmune Dysautonomia Srikanth Muppidi, MD, FAAN
02:50 PM - 03:00 PM PDT	Q&A	Questions, Answers, and Discussion Divyanshu Dubey, MD, FAAN, Anthony A. Amato, MD, FAAN, Srikanth Muppidi, MD, FAAN

Faculty Disclosures
Divyanshu Dubey, MD, FAAN	The institution of Dr. Dubey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx. The institution of Dr. Dubey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arialys. The institution of Dr. Dubey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB . Dr. Dubey has received research support from Department of Defense . Dr. Dubey has received research support from Department of Defense . Dr. Dubey has received research support from UCB. Dr. Dubey has received research support from David J. Tomassoni ALS Research Grant Program . Dr. Dubey has received intellectual property interests from a discovery or technology relating to health care. Dr. Dubey has received intellectual property interests from a discovery or technology relating to health care. Dr. Dubey has received intellectual property interests from a discovery or technology relating to health care. Dr. Dubey has received intellectual property interests from a discovery or technology relating to health care.
Anthony A. Amato, MD, FAAN	Dr. Amato has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Johnson & Johnson. Dr. Amato has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for argenx. Dr. Amato has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abscuro. Dr. Amato has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Amato has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Caballeta. Dr. Amato has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Takeda. Dr. Amato has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Amato has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Viridian Therapeutics. Dr. Amato has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medpace. Dr. Amato has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology. Dr. Amato has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for legal firms. The institution of Dr. Amato has received research support from NIH. Dr. Amato has received publishing royalties from a publication relating to health care.
Srikanth Muppidi, MD, FAAN	Dr. muppidi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion. Dr. muppidi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for argenx. Dr. muppidi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB/Ra Pharma. Dr. muppidi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Horizont Pharma. Dr. muppidi has received publishing royalties from a publication relating to health care.

��ɫ��

��ɫ��